We no longer support this browser. Using a supported browser will provide a better experience.

Please update your browser.

Close browser message

As a global leader, we deliver strategic advice and solutions, including capital raising, risk management, and trade finance services to corporations, institutions and governments.

Learn more about our solutions:

  

Serving the world's largest corporate clients and institutional investors, we support the entire investment cycle with market-leading research, analytics, execution and investor services.

Learn more about our solutions:

  

We are a leader in investment management, dedicating to creating a strategic advantage for institutions by connecting clients with J.P. Morgan investment professionals globally.

Learn more about our solutions:

    

Our financial advisors create solutions addressing strategic investment approaches, professional portfolio management and a broad range of wealth management services.

Learn more about our solutions:

    

Leverages cutting-edge technologies and innovative tools to bring clients industry-leading analysis and investment advice.

Learn more:

    

The latest news and announcements.

Learn more:

    

For company information and brand assets for editorial use.

Learn more:

    

The latest news and announcements.

Learn more:

    

In a fast-moving and increasingly complex global economy, our success depends on how faithfully we adhere to our core principles: delivering exceptional client service; acting with integrity and responsibility; and supporting the growth of our employees.

Learn more:

    

J.P. Morgan is a global leader in financial services, offering solutions to the world's most important corporations, governments and institutions in more than 100 countries. As announced in early 2018, JPMorgan Chase will deploy $1.75 billion in philanthropic capital around the world by 2023. We also lead volunteer service activities for employees in local communities by utilizing our many resources, including those that stem from access to capital, economies of scale, global reach and expertise.

Learn more:

    

With over 50,000 technologists across 21 Global Technology Centers, globally, we design, build and deploy technology that enable solutions that are transforming the financial services industry and beyond.

Learn more:

    

Technology Banner

For general inquiries regarding JPMorgan Chase & Co. or other lines of business, please call +1 212 270 6000.

Learn more:

      

For general inquiries regarding JPMorgan Chase & Co. or other lines of business, please call +1 212 270 6000.

Learn more:

      

March 30, 2022

The end of 2021 brought to a close the first major phase of LIBOR cessation with 24 of the 35 LIBOR tenors ceasing. 

The transition from non-USD LIBOR has proved successful, with the vast majority of transactions shifting to alternative reference rates before or at cessation. Synthetic LIBOR rates have been created for the residual tough legacy products referencing 1M, 3M and 6M tenors of GBP, and JPY LIBOR for a one-year period with no guarantee of extensions. However, while parties should work towards remediating these residual non-USD LIBOR transactions before 2023, industry focus has turned toward remediation of the more significant portfolio of USD LIBOR referencing transactions ahead of cessation on June 30, 2023. 

The Successful Adoption of SOFR

SOFR is now the dominant index used for new transactions in trading and lending markets, having replaced LIBOR in 2021.

U.S. regulators and national working groups have been clear on the necessity to transition away from USD LIBOR. They facilitated this move by supporting initiatives to improve liquidity in SOFR, and introducing measures to limit adoption of new USD LIBOR-referencing transactions.

The Commodity Futures Trading Commission’s (CFTC) phased “SOFR First” initiatives for switching trading conventions from USD LIBOR to SOFR across derivatives products, implemented in the second half of 2021, has led to a significant shift in liquidity towards SOFR. In the interbank markets, dealers have shifted the vast majority of their volumes from LIBOR to SOFR. Furthermore, between 90% and 100% of flow OTC markets across products and more than 50% of exchange traded interest rate futures contracts are now referencing SOFR.

In early March, the notional of SOFR swaps traded in the market was higher than that of LIBOR swaps for the first time.

Ben Kinney, Global Co-Head of Interest Rate Sales

An upward trend in SOFR liquidity is further attributed to the November 30, 2020 interagency statement notifying market participants of restrictions to dealing in new USD LIBOR transactions after 2021. In 2022, new USD LIBOR derivatives should only be executed for risk management purposes and should not be entered into if it results in increased market exposure to the benchmark. In the derivatives markets, unwinding trades, compressing portfolios of trades, hedging LIBOR or fixing risks are all permitted use cases in risk reduction of USD LIBOR portfolios.

The message from the U.S. regulators is clear: no more new use of USD LIBOR.

Conventions for SOFR

Conventions across products are now widely understood. Derivatives products have led the transition to a new normal after LIBOR following the publication of SOFR in 2018. Compounding in arrears is the preferred standard for tenors longer than overnight, with the exception of hedges to products referencing Term SOFR Rates. This convention has similarly been adopted as the preferred standard for securitizations. 

Other variations in overnight methodologies have been observed in non-loan cash products, including the SOFR-in-advance methodology used in U.S. adjustable-rate mortgages. The publication of an ARRC-endorsed forward-looking term rate in the CME Term SOFR Rates bridged the gap for those products where transition to an overnight rate has been difficult. This particularly applies to multi-lender facilities, middle market and trade finance loans, where forward-looking term rates have been accepted as appropriate use cases. CME Term SOFR has been the preferred convention globally for these U.S. dollar loans which is quoted in one month, three, six, and 12 month tenors.

Credit Spread Adjustments (CSAs) have been recommended by national working groups as part of pricing to SOFR, in order to try to maintain economic equivalence. However, with the rising rate environment and volatile global markets, the adoption of CSAs has varied, particularly in the loans market.

Credit spread adjustments are an evolving market practice. The spot spreads for both the one month and three month tenors between LIBOR and SOFR are significantly below the five-year historical averages so borrowers have been evaluating what to do as those spreads have moved.

Patricia Devine, Head of Corporate Banking, North America

Borrowers should consider the impact changing rates may have on CSAs for the duration of their loans contracts, and should consult their lenders on this topic when refinancing their LIBOR deals. 

Federal Legislation Around LIBOR

On March 15, 2022 U.S. President Biden signed into law the Consolidated Appropriations Act, 2022. It contains federal legislation to significantly reduce market disruption and outstanding risks associated with USD onventions across products are now widely understood. Derivatives products have led the transition LIBOR transition. Originally developed by the ARRC, the legislation will allow U.S. Law-based financial contracts unable to transition to adopt SOFR upon USD LIBOR cessation. Additionally, any agent with the discretion of selecting a successor rate will benefit from safe harbor provisions if they select SOFR. 

Legislation gives a certain outcome because people know what happens to their contracts post June 2023. It also provides fairness and equality because everyone’s receiving the same rate. 

Tom Pluta, Global Head of Linear Rates and Co-Head of North America Rates Trading

The enactment of federal legislation is a big step forward for tough legacy products, particularly bonds and securitizations, as well as consumer products such as adjustable-rate mortgages that typically are governed by state laws. However, while federal legislation will be effective in U.S.-law financial contracts, market participants who carry contracts governed by other jurisdictional laws must be aware that there is currently no equivalent legislation on the international front.

Next Steps in the LIBOR to SOFR Transition

The tools and conventions for remediation of legacy USD LIBOR are available today. Transaction volumes referencing USD LIBOR continue to decline and benchmark liquidity will only reduce going forward. The continued adoption and liquidity of SOFR in derivatives and cash markets, and the announcement of federal legislation to aid the transition of tough legacy products means that there has never been a better time to consider transition. 

We urge market participants to assess their remaining USD LIBOR referencing portfolios and have a strategy in place for transition as soon as possible. As always, J.P. Morgan stands ready to support and guide our clients through the transition process.

 

Podcast

Markets
Leaving LIBOR Part V: SOFR Takes Over
Market Matters
March 30, 2022
18:43
In this podcast episode, we discuss the latest developments in the transition away from the London Interbank Offered Rate (LIBOR) to the Secured Overnight Financing Rate (SOFR). With SOFR now the dominant index used for new transactions in trading and lending markets we discuss the implications for remaining USD LIBOR portfolios and what the recent Federal Legislation, aimed at reducing market transition risks, means for our clients.



This podcast was recorded on March 11th 2022.

The views in this podcast do not necessarily reflect the views of JPMorgan Chase and Co or its affiliates. Collectively JP Morgan. This communication is provided for information purposes only. JP Morgan normally makes a market and trades as principal insecurities, other financial products and other asset classes that may be discussed in this for additional disclaimers and regulatory disclosures. For additional disclaimers and regulatory disclosures, please consult: http://www.jpmorgan.com/disclosures/salesandtradingdisclaimer. For further information about benchmark reform and the transition away from LIBOR, please visit www.jpmorgan.com/global/markets/libor-sofr.

 

Related Insights

Leaving LIBOR: A Landmark Transition

Leaving LIBOR: A Landmark Transition

The move away from the London Interbank Offered Rate (LIBOR) is a global phenomenon that has the financial industry mobilizing ahead of a looming deadline.

Markets

Markets

Market-leading research and trade execution across multiple asset classes, including credit, equities and FX.

Less Than One Month Until LIBOR Ceases

Less Than One Month Until LIBOR Ceases

Take the final steps to ensure your organization is ready to trade without LIBOR.

SALES AND TRADING DISCLAIMER

FOR INSTITUTIONAL & PROFESSIONAL CLIENTS ONLY – This material is from a Sales and Trading department and is not a product of the Research Department.

This material has been prepared by personnel in the Sales and Trading Departments of one or more affiliates of JPMorgan Chase & Co. (together, “J.P. Morgan”) and not by J.P. Morgan’s Research Department and therefore, has not been prepared in accordance with legal requirements to promote the independence of research, including but not limited to, the prohibition on the dealing ahead of the dissemination of investment research. It is not a research report and is not intended as such. It is for distribution to institutional and professional clients only and is not intended for retail customer use.

It is provided on a confidential basis and may not be reproduced, redistributed or disseminated, in whole or in part, without the prior written consent of J.P. Morgan. Any unauthorized use is strictly prohibited.

Unless otherwise specifically stated, any views or opinions expressed herein are solely those of the individual author and/or the specific Sales and Trading area from which it originates and may differ from the views or opinions expressed by other areas of J.P. Morgan, including the Research Department.

This material is provided for information purposes only and does not bind J.P. Morgan in any way. It is not intended as a recommendation (except to the extent it is an “investment recommendation” under MAR (as defined below)) or an offer or solicitation (except to the extent covered by CFTC Rules (as defined below)) for the purchase or sale of any security or financial instrument, or to enter into a transaction involving any financial instrument or trading strategy, or as an official confirmation or official valuation of any transaction mentioned herein. Any pricing information provided is indicative only and does not reflect a level where J.P. Morgan is prepared to execute a trade. J.P. Morgan is not an advisor. Nothing in this material should be construed as investment, tax, legal, accounting, regulatory or other advice (including within the meaning of Section 15B of the Securities Exchange Act of 1934) or as creating a fiduciary relationship.

MAR Disclosure: Where this material is an “investment recommendation” as that term is defined in Article 3(1)(35) of the EU and UK Market Abuse Regulation (“MAR”), distribution of this material is subject to the relevant provisions of MAR. For more information, please consult: www.jpmm.com/#mardisclosures.

Research Disclosure: This material is not, and is not intended to be, a “research report”, “investment research” or “independent research” as may be defined in applicable laws and regulations worldwide. However, it may constitute “research” as defined in Recital 28 of the Commission Delegated Directive (EU) 2017/593 and in the Financial Conduct Authority’s Handbook.

Derivatives Disclosure: Where distribution of this material is subject to the rules of the U.S. Commodity Futures Trading Commission (“CFTC”), it is a “solicitation” of derivatives business generally only as that term is used within CFTC Rule 1.71 and 23.605 promulgated under the U.S. Commodity Exchange Act (the “CFTC Rules”).

Options Disclosure: Structured securities, options, futures and other derivatives are complex instruments and may involve a high degree of risk. Before entering into any such transactions, please ensure that you have read and understood the Options Clearing Corporation’s Characteristics and Risks of Standardized Options, also known as the options disclosure document (ODD) available at: http://www.theocc.com/about/publications/character-risks.jsp.

Exchange Traded Fund (“ETF”) Disclosure: Each U.S. registered ETF has filed a registration statement (including a prospectus) with the U.S. Securities and Exchange Commission. Each non-U.S. ETF will have its own offering documents as required by applicable law. No offer or sale of the ETFs described may be made except pursuant to the prospectus or offering documents, as applicable. The ETF’s prospectus and/or offering documents are available through the ETF issuer’s website; you should read these carefully before deciding to invest.

Transactions involving securities, financial instruments and strategies mentioned herein may not be suitable for all investors. You are solely responsible for deciding whether any investment or transaction is suitable for you based upon your investment goals, financial situation and tolerance for risk. If you deem it necessary, you must seek independent professional advice to ascertain the investment, legal, tax, accounting, regulatory or other consequences before investing or transacting.

 

Past or simulated past performance (including back-testing) is not indicative of future results. The investments discussed may fluctuate in price or value. Changes in rates of exchange may have an adverse effect on the value of investments. Any modelling, scenario analysis or other forward-looking information herein (such as projected cashflows, yields or returns) is intended to illustrate hypothetical results based on certain assumptions (not all of which will be specified herein). Actual events or conditions may differ materially from those assumed; therefore, actual results are not guaranteed.

All market prices, data and other information (including that which may be derived from third party sources believed to be reliable) are not warranted as to completeness or accuracy and are subject to change without notice. J.P. Morgan disclaims any responsibility or liability to the fullest extent permitted by applicable law, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. The information contained herein is as of the date and time referenced only, and J.P. Morgan does not undertake any obligation to update such information.

J.P. Morgan may have positions (long or short), effect transactions or make markets in securities or financial instruments mentioned herein (or related instruments), or provide advice or loans to, or participate in the underwriting or restructuring of the obligations of, the legal entities mentioned herein. The Sales and Trading personnel who prepared this material may be compensated in part based on trading activity. Moreover, Sales and Trading personnel may have acted on the basis of this material either on behalf of J.P. Morgan or, where permitted, in their personal accounts. As such, this material should not be relied upon as either objective or independent from the interests of J.P. Morgan and its associated personnel, which interests may conflict with your interests.

Securities, financial instruments or strategies mentioned herein may not be available in all jurisdictions or to all clients. Clients should contact their salespersons at, and execute transactions through, a J.P. Morgan entity appropriately licensed in the client’s home jurisdiction unless governing law permits otherwise.

Product names, company names and logos mentioned herein are trademarks or registered trademarks of their respective owners.

© 2022 JPMorgan Chase & Co. All rights reserved. J.P. Morgan is a marketing name for investment banking businesses of JPMorgan Chase & Co. and its subsidiaries and affiliates worldwide. Bank products and services, including certain lending, derivative and other commercial banking activities, are offered by JPMorgan Chase Bank N.A. (JPMCB), including through its authorized branches and other global affiliates registered with local authorities as appropriate. Securities products and services, including execution services, are offered in the United States and in other jurisdictions worldwide by J.P. Morgan Securities LLC (JPMS LLC), in EMEA by J.P. Morgan Securities plc (JPMS plc), J.P. Morgan AG (JPM AG) and by other appropriately licensed global affiliates. JPMCB, JPMS LLC, JPMS plc and JPM AG are principal subsidiaries of JPMorgan Chase & Co. For information on which legal entities offer investment banking products and services in each jurisdiction, please consult: www.jpmorgan.com/ib-legal-entities. For important disclosures in respect of securities transactions, please consult: www.jpmorgan.com/securities-transactions and in respect of over-the-counter equity derivatives transactions, please consult: www.jpmorgan.com/otc-equity-derivative-transactions.

Country Specific Disclosures

Brazil: J.P. Morgan Ombudsman: 0800-7700847. E-mail: ouvidoria.jp.morgan@jpmorgan.com.

Singapore: For important Singapore disclosures, please consult: https://www.jpmorgan.com/country/GB/EN/disclosures/apac-legal-entity-information#Singapore.

South Africa: J.P. Morgan Securities plc is exempt from the licensing provisions of the Financial Advisory and Intermediary Services Act, 2002.

For additional regulatory disclosures, please consult: www.jpmorgan.com/disclosures.